← SynDRA
TAPRENEPAG
SynDRA canonical compound SYN0033236 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PTGER2 |
|---|
| Mechanism of action | prostaglandin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER2 FULL AGONIST
- prostaglandin receptor agonist
- PTGER2 AGONIST
- Prostanoid EP2 receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADGRF1
- NEIL2
- HTR1A
- HTR1B
- HTR1E
- HTR2A
- HTR2B
- HTR2C
- HTR6
- MBD4
- MPG
- MUTYH
- NEIL1
- OPRD1
- ADRA1A
- OPRK1
- OPRM1
- PTGER1
- PTGER3
- PTGER4
- PTGIR
- S1PR1
- SIGMAR1
- SMUG1
- TDG
- TMEM97
- HRH4
- HRH3
- HRH2
- HRH1
- ADRA1B
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB2
- AGTR1
- APLNR
- C5AR1
- CHRM1
- CHRM3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- CP-544326
- CP544326
- PF04217329
- Taprenepag isopropyl
- PF-04217329
- PF-4217329
- 9CD894KUMJ
- RefChem:932569
- DTXCID00148678
- MFCD18633300
- Taprenepag [USAN:INN]
- UNII-9CD894KUMJ
- TAPRENEPAG [INN]
- Taprenepag (USAN/INN)
- TAPRENEPAG [USAN]
- TAPRENEPAG [WHO-DD]
- Taprenepag(CP-544326)?
- GTPL5816
- orb1304459
- SCHEMBL3318549
- SCHEMBL29379291
- EX-A941
- CFB18780
- BDBM50016953
- AKOS030632799
- CS-5590
- AC-36845
- AS-76944
- DA-78195
- HY-14899
- NS00072952
- D09968
- AN-584/43522716
- F870122
- BRD-K88854110-001-01-5
- GNO
Look up TAPRENEPAG in the interactive SynDRA portal →